PSU PRESS RELEASE
NRDC inks Technology Commercialization Agreement for AYUSH
New Delhi. NRDC inks Technology Commercialization Agreement for AYUSH-82; AYUSH SG and Herbal Formulation for Anti-Arthritis Dr. H. Purushotham CMD, National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific and Industrial Research (DSIR), Ministry of Science & Technology, Govt. of India,New Delhi .
Informed through the press release that NRDC and M/s Ridhi Sidhi Medicare, New Delhi have entered into License Agreements for commercialization of AYUSH-82, an ayurvedic formulation for management of Diabetes, Ayush–S.G for Rheumatoid Arthritis and Herbal Formulation for Anti- Arthritis.
Read Also : ERES-XXXIX incorporated as wholly subsidiary of REC Power Development& consultancy Limited
News Must Read
- Shri. Bikram Ghosh takes charge as Director (Finance) in WCL
- SBI to change debit cards maintenance normal from 1 April, 2024
- NMDC excels at Governance Now 10th PSU Awards
- NTPC Group ties up JPY 30 billion funding from JBIC
- Jabalpur Airport connects Madhya Pradesh to other cities
- Best Organisations for Women title to PowerGrid
- Air India Faces Heavy Fine from DGCA of Rs 80 Lakh
- NCL's mega achievement; surpasses 500 Million Cubic Meters of Overburden
- RailTel bags major order from CDAC worth Rs 36 crore
- ICRA withdraws long term rating of NCDs of ONGC